Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

General Information

Summary The goal of this clinical trial is to assess the safety and tolerability of the surgical transplantation of dopaminergic progenitor cells into the brains of participants with Parkinson's disease. The transplanted dopaminergic cells will be derived from the participant's own skin cells.
Description This Phase I, open-label clinical trial aims to assess the feasibility and safety of autologous midbrain dopaminergic progenitor cell (mDAP) transplantation for the treatment of Parkinson's disease. mDAPs will be produced for each participant from a fibroblast sample and then transplanted bilaterally into the putamen under general anesthesia. The study will assess the safety and tolerability of the cell transplant procedure through clinical assessments and neuroimaging (CT, MRI and 18F-DOPA PET) over a 2-year follow-up period.
Clinical trials phase Phase 1
Start date (estimated) 2024-12-01
End date (estimated) 2028-12-31
Clinical feature
Label Parkinson's disease
Link http://purl.obolibrary.org/obo/DOID_14330
Description A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.; Xref MGI. OMIM mapping confirmed by DO. [SN].

Administrative Information

NCT number NCT06687837
ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=NCT06687837
Other study identifiers
Name 2024P001089
Source weblink https://clinicaltrials.gov/study/NCT06687837
Regulatory body approval
Name Food and Drug Administration (FDA)
Country
United States
Public contact
Email jschweitzer1@mgh.harvard.edu
Public email jschweitzer1@mgh.harvard.edu
First name Jeffrey S
Last name Schweitzer
Phone +1 617 726 1799
City Boston
Country
United States
Address freetext Massachusetts General Hospital Boston, Massachusetts, United States, 02114
Sponsors Jeffrey S. Schweitzer, MD, PhD

Cells

Which differentiated cell type is used
Label dopaminergic neuron
Link http://purl.obolibrary.org/obo/CL_0000700
Description A neuron that releases dopamine as a neurotransmitter.

Recruitment

Recruitment Status Recruiting
Estimated number of participants 8